Jetboy
New member
It's perfectly valid to compare this novel coronavirus with the flu.
Per the video I posted earlier, non-novel coronavirus makes up 5-14% of all flu viruses in any given year.
This one's different because it's new, so the questions are what's the excess infection, illness, and mortality rates over the norm, where's a vaccine, and when will people's immune systems adjust.
A little statistics is a dangerous thing. The low initial mortality rate is not representative of a higher level of infection. For example, once you run out of ventilators, each additional ARD patient has a vastly different statistical probability of survival. That is not similar to the flu - at least not any flu that's occurred in any of our lifetimes. The second order effects are not similar and one is in an exponential growth rate that has vastly higher feedback in mortality rate from higher levels of spread than the other.
Comparing current mortality rate with a very limited initial spread is analogous to looking at a quarterly income statement from GE and one from a startup tech company and claiming that you can make long term valuation or long term planning decisions for both companies in a comparable way on that basis. The number has the same format and ostensibly measures the same thing - but we certainly wouldn't look to those numbers as the basis of making planning choices.